4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow Autoinjector: new trials by email Literature Review of Autoinjector trials Research Report on Autoinjector
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Safety, Tolerability and Pharmacokinetics Study of VRDN-003 in Participants With Thyroid Eye Disease (TED) VRDN-003, Autoinjector - Thyroid Eye Disease | Phase 3 | Completed | Viridian Therapeutics, Inc. | 87 | 2025-07-01 | 2026-06-25 |
| A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis Risankizumab, Autoinjector - Psoriasis | Phase 3 | Completed | AbbVie | 108 | 2019-06-04 | 2021-05-11 |
| Usability of an AI for M923 in Subjects With Moderate to Severe RA M923, Autoinjector - Rheumatoid Arthritis | Phase 3 | Completed | Momenta Pharmaceuticals, Inc. | 33 | 2016-04-01 | 2018-05-16 |
| Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications Intramuscular route of active treatment, Intravenous route of active treatment - Status Epilepticus | Phase 3 | Completed | Robert Silbergleit | 1023 | 2009-06-01 | 2016-06-17 |
Arthritis, Rheumatoid (1) · Graves Ophthalmopathy (1) · Psoriasis (1) · Seizures (1) · Status Epilepticus (1)
AbbVie (1) · Momenta Pharmaceuticals, Inc. (1) · Robert Silbergleit (1) · Viridian Therapeutics, Inc. (1)
United States (4)
Daniel H Lowenstein, MD (1) · John Caminis, MD (1) · Robert Silbergleit, MD (1) · Valerie L Durkalski, PhD (1)
PMID 21967361, PMID 22335736, PMID 22506949, PMID 24001080, PMID 35987977
U01NS056975 (1)